Research and Analysis of Price Adjustment Program for Digestive Drugs in China

Recently, the National Development and Reform Commission issued a notice and decided to adjust the maximum retail price limit for some drugs of the digestive system from May 1. The drug price adjustment involved a total of 53 varieties, more than 300 dosage form specifications, an average decline of 17%, of which high-priced drugs on average decreased by 22%, is expected to reduce the burden on the people each year more than 3 billion yuan.

The responsible person of the National Development and Reform Commission pointed out that since the reform of the medical and health system was deepened, the competent price departments at all levels have actively promoted the reform of drug prices in accordance with the requirements of medical reform, and the price order has gradually improved, and the price behavior has gradually become more standardized.

With the deepening of medical reform, some deep-seated contradictions, such as institutional and structural issues, have begun to appear. The community has paid more attention to the issue of drug prices, and has also put forward new requirements and new expectations for drug prices. The National Development and Reform Commission will intensify the reforms, study the drug price management system adapted to the new situation of the medical reform, and further improve the price formation mechanism.